Mar 25, 2024
Linkage of Cancer and Lupus in Gliomas Patients
Mar 04, 2024
Invitation to Participate in STOP-PC Clinical Trial
Jan 16, 2024
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients
Dec 18, 2023
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant
Nov 28, 2023
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.
Nov 15, 2023
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results
Aug 25, 2023
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023
Aug 23, 2023
Sapu BioScience and Cromos Pharma initiating P201 - A Registrational trial for OT-101 in Pancreatic Cancer
Jun 12, 2023
Oncotelic Launches PR Chatbot
May 16, 2023
Oncotelic Participating at 2023 BIO International Convention
1
2
3
4
5
6
<<
<
>
>>
Copyright © 2021 Oncotelic Inc., a TGF ImmunoOncology Company. All rights reserved.
Privacy
